Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells

doi:10.3748/wjg.v17.i3.313

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5225)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

385

HTML

4569

Figures (1-5)

271

Sum=5225

Jan 21, 2011 (publication date) through Nov 17, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 21, 2011; 17(3): 313-321
Published online Jan 21, 2011. doi: 10.3748/wjg.v17.i3.313

Full Size Figure Download Figure

Figure 1 Octreotide at a concentration of 10^-8 mol/L had a statistically significant inhibitory effect on cellular proliferation of HepG2 hepatocellular carcinoma cells, compared to untreated cells. Lower concentrations caused an initial increase in proliferation. The results represent the mean of 8 different experiments ± SE (^bP < 0.01, ^dP < 0.001). NS: Not significant.

Citation: Tsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol 2011; 17(3): 313-321
URL: https://www.wjgnet.com/1007-9327/full/v17/i3/313.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i3.313